American Healthcare REIT, Inc.
AHR
NYSE·Real Estate·REIT - Healthcare Facilities·Mkt cap $11.3B
$54.72
▼ -1.87%
P/E
94.04
Mkt Cap
$11.3B
52-Wk Range
$40.00–$58.70
52-Week Range
$40.00 - $58.70
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 27.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Experienced Management Team
- Diversified Geographic Portfolio
- Proven Track Record in Healthcare Real Estate
- Strategic Asset Selection
Bear Case
2 risks
- Low volatility (beta 0.7).
- High premium - requires strong execution
Growth
Moderate growth ahead
Aging Population Demographics
Value
High premium - requires strong execution
Momentum
Strong
+19.7% over 3m
Quality
Thin
Strong fundamentals
Dividend
Modest
1.83% yield
Smart-money signal
Who's buying AHR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.16 vs $0.14 consensus (+16.6% surprise). Revenue of $671.0M vs $645.3M expected (+4.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+16.6%
Revenue trend · last 8Q
—
—
+12%
+8%
+8%
+9%
+11%
+20%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$504.6M
$523.8M
$542.7M
$540.6M
$542.5M
$572.9M
$604.1M
$650.8M
Margins · last 8Q
Gross
—
Operating
—
Profit
3.6%
Wall Street consensus
8 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Scotiabank · Sep 2, 2026
vs Industry
How AHR stacks vs REIT - Healthcare Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related